Pharmafile Logo
Pharmafocus logo
Advanced Search

remdesivir

Showing 14 posts of 29 posts found.

remdesivir_ulrich_perrey

Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients

June 5, 2020
Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir

Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …

News
remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …

News
david_paul_morrisbloomberg

Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows

June 2, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …

News
shutterstock_243110086

First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment

May 29, 2020
Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir

The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …

News
generics

Gilead signs deal with generic drugmakers to expand global supply of remdesivir

May 13, 2020
Research and Development COVID-19, coronavirus, remdesivir

Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them …

News
japan_mhlw

Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19

May 12, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir

Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …

News
gilead-sciences

FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients

May 4, 2020
Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir

Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …

News
gilead-speeds-manufacture-of-experimental-covid-19-drug-biospace-4-5-20-495x350

Two studies reveal “positive” data for Gilead’s remdesivir in hospitalised COVID-19 patients

April 30, 2020
Research and Development COVID-19, Gilead, coronavirus, remdesivir

The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the …

News
gilead-sciences

Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial

April 24, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …

News
800px-rhesus_macaque_macaca_mulatta_in_kinnarsani_ws_ap_w_img_5792

Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial

April 20, 2020
Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir

A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …

News

Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days

April 17, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …

News
gilead-sciences

Gilead halts COVID-19 remdesivir trial due to enrolment issues, efficacy of the drug uncertain

April 16, 2020
Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

A clinical trial in China investigating Gilead’s antiviral therapy remdesivir as a potential treatment for COVID-19 has been placed on …

News
gilead-sciences

Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients

April 14, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …

News
flag_of_world_health_organization_at_un_city

WHO launches “historic” multinational study to investigate most promising COVID-19 therapies

March 30, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir

The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025